Board announcement: CEO resignation
6 December 2018 Message from the Chair On behalf of the Board of BioMelbourne Network, I advise our Members, partners and associates that our CEO, Dr Krystal Evans, has tendered her resignation. Krystal will leave us in the…
2019 ARCS Annual Conference: call for session and program proposals extended
Interested parties from industry, research institutions, government and academia involved in development through to commercialisation of therapeutics (from bench to bedside) are invited to submit session proposals and program suggestions for the 2019 ARCS Annual Conference to be…
BioEYES looking for industry partners
3 December 2018 BioEYES Australia is a science outreach program that covers curricula in genetics, cell biology and developmental biology, but more importantly excites students about the thrill of scientific discovery. Over a 1 week incursion, students set…
Nominations open for 2019 Women in Leadership Awards
Do you know a woman who is making an outstanding contribution to the health and biotech sector? Why not nominate her for a 2019 BioMelbourne Network Women in Leadership Award? Awards are made in three categories, recognising women in…
Victoria’s health industry welcomes Andrews government
30 November 2018 On behalf of its members, BioMelbourne Network congratulates the Hon Daniel Andrews MP and the Victorian Labor party on their re-election at the 2018 state election. BioMelbourne Network CEO Dr Krystal Evans welcomes the opportunity…
WILD Program launches within the Victorian STEM sector
22 November 2018 The Women in Leadership Development (WILD) Program announced its launch yesterday, with the first intake of women in the science, technology, engineering and maths (STEM) sector. The WILD Program helps build on the qualifications, skills…
ARC Centre for Personalised Therapeutics Technologies launches in Melbourne
22 November 2018 The ARC Centre for Personalised Therapeutics Technologies launched in Melbourne this week. The centre, headquartered at the Department of Pharmacology and Therapeutics at the University of Melbourne, aims to advance and deploy new technologies that will remove…
Recap: Meet the Minister – a ‘fireside chat’ with Philip Dalidakis, MP
This BioMelbourne Network event recap was written by our Marketing and Communication Assistant, Ms Michelle Steeper. Leaders of Victoria’s health industry joined a Town Hall conversation with the Minister for Innovation and Digital Economy, Hon Philip Dalidakis, MP on…
BioMelbourne Network opposes cuts to the R&D Tax Incentive
5 November 2018 BioMelbourne Network has made a submission to the Senate Inquiry regarding the changes to the R&D Tax Incentive as outlined in the Treasury Laws Amendment. BioMelbourne Network is opposed to the proposed changes to the…
Novartis and BioCurate announce first collaboration to accelerate early stage drug discovery
31 October 2018 Biomedical research company BioCurate Pty Ltd and Novartis today announced that they will collaborate on early stage drug discovery projects that have potential to address an unmet need. This collaboration marks BioCurate’s first with the…
Watermark a first-mover with customised website live chat platform
Being on the leading edge of innovation and intellectual property, Watermark is paving the digital path for IP attorney and legal services firms with the unveiling of a website chat bot. Executive General Manager Mark Bisset says the…
Recap: Meet the Shadow Minister – a ‘fireside chat’ with David Southwick, MP
This BioMelbourne Network event recap was written by our Policy and Research Officer, Dr Kim Pham. Industry leaders, innovators, peak bodies and ASX-listed companies in the health industry recently participated in a Town Hall conversation with Shadow Minister for…
